These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 29510666

  • 21. Factors associated with sputum culture conversion in multidrug-resistant pulmonary tuberculosis.
    Velayutham B, Nair D, Kannan T, Padmapriyadarsini C, Sachdeva KS, Bency J, Klinton JS, Haldar S, Khanna A, Jayasankar S, Swaminathan S.
    Int J Tuberc Lung Dis; 2016 Dec; 20(12):1671-1676. PubMed ID: 27931345
    [Abstract] [Full Text] [Related]

  • 22. Validity of Time to Sputum Culture Conversion to Predict Cure in Patients with Multidrug-Resistant Tuberculosis: A Retrospective Single-Center Study.
    Javaid A, Ahmad N, Afridi AK, Basit A, Khan AH, Ahmad I, Atif M.
    Am J Trop Med Hyg; 2018 Jun; 98(6):1629-1636. PubMed ID: 29611497
    [Abstract] [Full Text] [Related]

  • 23. Predictors of delayed culture conversion in patients treated for multidrug-resistant tuberculosis in Pakistan.
    Qazi F, Khan U, Khowaja S, Javaid M, Ahmed A, Salahuddin N, Hussain H, Becerra MC, Golub JE, Khan AJ.
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1556-9, i. PubMed ID: 22008773
    [Abstract] [Full Text] [Related]

  • 24. Time to sputum culture conversion and its associated factors among multidrug-resistant tuberculosis patients in Eastern Africa: A systematic review and meta-analysis.
    Assemie MA, Alene M, Petrucka P, Leshargie CT, Ketema DB.
    Int J Infect Dis; 2020 Sep; 98():230-236. PubMed ID: 32535296
    [Abstract] [Full Text] [Related]

  • 25. Polymorphisms in the vitamin D receptor gene are associated with reduced rate of sputum culture conversion in multidrug-resistant tuberculosis patients in South Africa.
    Magee MJ, Sun YV, Brust JCM, Shah NS, Ning Y, Allana S, Campbell A, Hui Q, Mlisana K, Moodley P, Gandhi NR.
    PLoS One; 2017 Sep; 12(7):e0180916. PubMed ID: 28700743
    [Abstract] [Full Text] [Related]

  • 26. Prognostic factors of treatment among patients with multidrug-resistant tuberculosis in Egypt.
    Gadallah MA, Mokhtar A, Rady M, El-Moghazy E, Fawzy M, Kandil SK.
    J Formos Med Assoc; 2016 Nov; 115(11):997-1003. PubMed ID: 26696497
    [Abstract] [Full Text] [Related]

  • 27. Community-based treatment for multidrug-resistant tuberculosis in rural KwaZulu-Natal, South Africa.
    Heller T, Lessells RJ, Wallrauch CG, Bärnighausen T, Cooke GS, Mhlongo L, Master I, Newell ML.
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):420-6. PubMed ID: 20202299
    [Abstract] [Full Text] [Related]

  • 28. Time to sputum culture conversion and treatment outcome among the first cohort of multidrug resistant tuberculosis patients in a high burden country.
    Ige OM, Oladokun RE.
    Indian J Tuberc; 2018 Oct; 65(4):322-328. PubMed ID: 30522620
    [Abstract] [Full Text] [Related]

  • 29. Factors associated with time to sputum culture conversion of rifampicin-resistant tuberculosis patients in Klaipeda, Lithuania in 2016-2019: a cohort study.
    Diktanas S, Korotych O, Sereda Y, Gozalov O, Rubcova O, Achar J.
    Monaldi Arch Chest Dis; 2021 Jan 14; 91(1):. PubMed ID: 33470085
    [Abstract] [Full Text] [Related]

  • 30. Chest radiograph findings and time to culture conversion in patients with multidrug-resistant tuberculosis and HIV in Tugela Ferry, South Africa.
    Brust JC, Berman AR, Zalta B, Haramati LB, Ning Y, Heo M, van der Merwe TL, Bamber S, Moll AP, Friedland GH, Shah NS, Gandhi NR.
    PLoS One; 2013 Jan 14; 8(9):e73975. PubMed ID: 24040132
    [Abstract] [Full Text] [Related]

  • 31. Time to culture conversion and regimen composition in multidrug-resistant tuberculosis treatment.
    Tierney DB, Franke MF, Becerra MC, Alcántara Virú FA, Bonilla CA, Sánchez E, Guerra D, Muñoz M, Llaro K, Palacios E, Mestanza L, Hurtado RM, Furin JJ, Shin S, Mitnick CD.
    PLoS One; 2014 Jan 14; 9(9):e108035. PubMed ID: 25238411
    [Abstract] [Full Text] [Related]

  • 32. Time to sputum culture conversion and its associated factors among drug-resistant tuberculosis patients: a systematic review and meta-analysis.
    Wenlu Y, Xia Z, Chuntao W, Qiaolin Y, Xujue X, Rong Y, Dan S, Xi Y, Bin W.
    BMC Infect Dis; 2024 Feb 07; 24(1):169. PubMed ID: 38326758
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study.
    Huang Z, Qin C, Du J, Luo Q, Wang Y, Zhang W, Zhang X, Xiong G, Chen J, Xu X, Li W, Li J.
    J Antimicrob Chemother; 2015 Feb 07; 70(2):456-62. PubMed ID: 25266071
    [Abstract] [Full Text] [Related]

  • 34. Alcohol drinking delays the rate of sputum smear conversion among DR-TB patients in northwest Ethiopia; A retrospective follow-up study.
    Merid MW, Muluneh AG, Kassa GM.
    PLoS One; 2022 Feb 07; 17(3):e0264852. PubMed ID: 35263367
    [Abstract] [Full Text] [Related]

  • 35. Time to detection in liquid culture of sputum in pulmonary MDR-TB does not predict culture conversion for early discharge.
    Rieu R, Chang C, Collin SM, Fazekas J, Dassanaike S, Abbara A, Davidson RN.
    J Antimicrob Chemother; 2016 Mar 07; 71(3):803-6. PubMed ID: 26661394
    [Abstract] [Full Text] [Related]

  • 36. Linezolid in the treatment of MDR-TB: a retrospective clinical study.
    Xu HB, Jiang RH, Li L, Xiao HP.
    Int J Tuberc Lung Dis; 2012 Mar 07; 16(3):358-63. PubMed ID: 22640450
    [Abstract] [Full Text] [Related]

  • 37. Influence of previous tuberculosis treatment history on acid-fast bacilli smear and culture conversion.
    Lee J, Lee BJ, Yoon HI, Lee CT, Lee JH.
    Int J Tuberc Lung Dis; 2012 Oct 07; 16(10):1344-8. PubMed ID: 23107634
    [Abstract] [Full Text] [Related]

  • 38. Time to sputum culture conversion and its determinants among Multi-drug resistant Tuberculosis patients at public hospitals of the Amhara Regional State: A multicenter retrospective follow up study.
    Yihunie Akalu T, Muchie KF, Alemu Gelaye K.
    PLoS One; 2018 Oct 07; 13(6):e0199320. PubMed ID: 29927980
    [Abstract] [Full Text] [Related]

  • 39. Treatment outcomes of multidrug-resistant tuberculosis patients in Zhejiang, China, 2009-2013.
    Zhang L, Meng Q, Chen S, Zhang M, Chen B, Wu B, Yan G, Wang X, Jia Z.
    Clin Microbiol Infect; 2018 Apr 07; 24(4):381-388. PubMed ID: 28712668
    [Abstract] [Full Text] [Related]

  • 40. Implementation of the INNO-LiPA Rif. TB® line-probe assay in rapid detection of multidrug-resistant tuberculosis in Latvia.
    Skenders GK, Holtz TH, Riekstina V, Leimane V.
    Int J Tuberc Lung Dis; 2011 Nov 07; 15(11):1546-52, i. PubMed ID: 22008771
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.